Table 1.

Diagnosis cohort (N = 1268). Demographic and baseline characteristics.

Characteristic	Mean	Median	Range	N	(%)
Age, years	64.9	67.7	18–98	1268	100
<65				540	42.6
≥65				728	57.4
Sex				1268	100
Male				712	56.2
Female				556	43.8
ECOG				1075	100
0				420	39.1
1				452	42.0
2				135	12.6
3				53	4.9
4				15	1.4
Not available				193
WBC (×109/L)	32.8	8.8	0.24–407	1118
BM blast cells, %	53.4	52.0	0–100	1026
Creatinine, mg/dL	1.1	0.90	0.28–10.3	1071
MRC cytogenetic profile				1011	100
Favorable				57	5.6
Intermediate				178	17.6
Unfavorable				269	26.6
Normal karyotype				507	50.1
Not available				257
AML FAB subtype				715	100
M0				88	12.3
M1				144	20.1
M2				126	17.6
M4				173	24.2
M5				144	20.1
M6				31	4.3
M7				9	1.3
Not available				553
Therapeutic approach				1268	100
Intensive				695	54.8
Non–intensive				513	40.5
Supportive care only				60	4.7
Type of AML				1268	100
De novo				920	72.6
Secondary				348	27.4